actualidad

ENE 14

iVascular launches its new DEB range: luminor 14. Luminor 35 y essential

iVascular announces the launch of its range of drug-eluting balloons (Drug Elutting Balloon , DEB) with immediate worldwide availability


iVascular announces the launch of its range of drug-eluting balloons (Drug Elutting Balloon , DEB) with immediate worldwide availability.

luminor 14 is a balloon catheter compatible with 0.014” guide wire, with coaxial design (OTW), suitable for widening or opening stenosis of femoral, popliteal and infrapopliteal; and is presented with a working catheter length of 100 and 150 cm, balloon diameter between 1.5 and 4 mm and balloon lengths from 40 to 200 mm.

luminor 35 is a balloon catheter compatible with 0.014” guide wire, with coaxial design (OTW), indicated for the expansion or opening of stenosis of the femoropopliteal sector and renal arteries; for the treatment of obstructive lesions of original or artificial arteriovenous fistulae; and for stent post-dilatation in the peripheral vascular system. luminor 35 is presented with catheter’s working length of 80 and 140 cm, balloon diameters between 5 and 7 mm and balloon lengths from 20 to 150 mm

essential is a balloon catheter compatible with 0.014” guide wire, with rapid exchange (RX) design, indicated for balloon dilatation of the stenotic portion of a coronary artery or the stenosis of bypass grafts substituting the coronary arteries, including small vessels, as well as for residual stenosis after balloon or endoprosthesis treatment, and pre and post-dilatation of coronary stents, in order to improve myocardial perfusion

iVascular has developed its own coating technology known as TransferTech whereby an homogeneous and precise nano-deposition of microcrystalline paclitaxel is achieved, which yields a fast and quantitative drug transfer to the arterial wall and a high residence time of the drug in the focus of injury. Thanks to Transfertech, a multilayer and ultrathin coating is deposited which provides greater adherence to the balloon so that drug stability is guaranteed and the detachment of particles is avoided during navigation.

The design of iVascular catheters, widely proven in oceanus 14, oceanus 35 and xperience bare balloon catheters, endorses the new DEB range with very high proximal pushability and progressive distal flexibility, plus the best deflation rates existing in the market. Furthermore, the use of low profile, conical, non-traumatical tips ensures superb crossability.

Preclinical data on swine model N = 51 with histological and angiographical follow-up at 28 days show how iVascular DEBs exhibit significantly less restenosis than bare balloons and up to a 23% less than other DEBs available in the market, ensuring their safety and efficacy.

Share
0

MAY 13

iVascular Brasil

iVascular obtiene la certificación ANVISA de buenas prácticas de fabricación consolidando así su posición en el mercado Brasileño.


iVascular obtiene la certificación ANVISA de buenas prácticas de fabricación consolidando así su posición en el mercado Brasileño.

Share
0
heart